SK Biopharmaceuticals Co., Ltd. ( 326030.KS) - Stock Earnings
326030.KS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | 23.3 billion KRW | 144.4 billion KRW |
| 2025Q2 | 32.9 billion KRW | 176.3 billion KRW |
| 2025Q3 | 74.1 billion KRW | 191.7 billion KRW |
326030.KS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -139.4 billion KRW | 246.2 billion KRW |
| 2023 | -32.9 billion KRW | 354.9 billion KRW |
| 2024 | 240.7 billion KRW | 547.6 billion KRW |
326030.KS
Price: ₩88,100
52 week price:
Exchange: KSC
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 8.1 trillion